Teixeira FV, Parra RS, Feres O, Kotze PG. Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics [Internet]. 2019 Oct. 9 [cited 2024 Jul. 4];74:e1424. Available from: https://periodicos.usp.br/clinics/article/view/163038